Protein matrix vaccines of improved immunogenicity

Details for Australian Patent Application No. 2010292195 (hide)

Owner Matrivax Research & Development Corp.

Inventors Killeen, Kevin P.; Griffin IV, Thomas J.; Thanawastien, Ann

Agent Davies Collison Cave

Pub. Number AU-A-2010292195

PCT Pub. Number WO2011/031893

Priority 61/276,183 09.09.09 US

Filing date 9 September 2010

Wipo publication date 17 March 2011

International Classifications

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/112 (2006.01) Medicinal preparations containing antigens or antibodies - Salmonella

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/031893 Priority application(s): WO2011/031893

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010292198-PI3 kinase inhibitors and uses thereof

2010292192-Cancer stem cell-targeted and drug resistant cancer therapy